Garvey WT, Frias JP, Jastreboff AM, le Roux CW, Sattar N, Aizenberg D, Mao H, Zhang S, Ahmad NN, Bunck MC, et al
GLP-1 medications have emerged as a valuable addition to the arsenal of treatments for type 2 diabetes, offering benefits such as improved blood sugar control, weight loss, and cardiovascular protection
If you're tolerating treatment well, the escalation can proceed as planned
Glucagon-like peptide-1 receptor agonists in type 2 diabetes: a meta-analysis of randomized clinical trials
40,77,78 However, a recent study demonstrated in mice that secreted insulin in response to GSIS mediates insulinostatic actions via insulin receptor on islet beta-cells
DEXA/CT, dual-energy X-ray absorptiometry/computed tomography